You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Sale Disclosure
Bernstein Harold · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$133.45K
Bernstein Harold President, R&d & CMO
MAZE
Maze Therapeutics
MAZE
Transaction date
Sep 3, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed 1 day later
MAZE daily price context
Close on/before transaction
$25.87
Sep 3, 2026
First close after public filing
$26.37
Sep 8, 2026
30-day return after filing
+0.23%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,130 shares @ $26.01
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002050172-26-000034
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$270.11K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE Current | Sale | Sep 3, 2026 | $133.45K |
| Maze Therapeutics, Inc. MAZE | Sale | Sep 3, 2026 | $1.52K |
| Maze Therapeutics, Inc. MAZE | Sale | Sep 2, 2026 | $118.19K |
| Maze Therapeutics, Inc. MAZE | Sale | Sep 2, 2026 | $16.95K |